Recent studies have demonstrated that a higher density of CD4 naive T cells, regulatory T cells, and M2 macrophages is closely associated with a worse clinical prognosis in many malignant tumors, including COAD (Komohara et al., 2016; Speiser et al., 2016; Labanieh et al., 2018). Here, CD4 is linked to cancer.